Showing 1 - 6 results of 6 for search 'Byron L. Lam', query time: 0.02s Refine Results
  1. 1
    Severe visual loss from concurrent fulminant idiopathic intracranial hypertension and malignant arterial hypertension: Prompt suspicion matters

    Severe visual loss from concurrent fulminant idiopathic intracranial hypertension and malignant arterial hypertension: Prompt suspicion matters by Bashaer Aldhahwani, Serena M. Shah, Hong Jiang, Byron L. Lam

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Fundus Autofluorescence in Inherited Retinal Disease: A Review

    Fundus Autofluorescence in Inherited Retinal Disease: A Review by Jin Kyun Oh, Omar Moussa, Byron L. Lam, Jesse D. Sengillo

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Outcomes of genetic testing for Usher syndrome in a diverse population cohort from South Florida

    Outcomes of genetic testing for Usher syndrome in a diverse population cohort from South Florida by Zachary J. Cromar, Ryan Chen, Tamara Juvier Riesgo, Denise Yan, Lindsay Dawn Verma, Zhengyi Chen, Susan H. Blanton, Byron L. Lam, Xue Zhong Liu

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    To do or not to do: Large-dose steroid treatment for severe vision loss secondary to compressive inflammatory optic neuropathy in the setting of invasive fungal sinusitis

    To do or not to do: Large-dose steroid treatment for severe vision loss secondary to compressive inflammatory optic neuropathy in the setting of invasive fungal sinusitis by Charissa H. Tan, Benjamin I. Meyer, Colin Kim, Mohammed Raja, Jaylou M. Velez Torres, Jordan Colson, Sander R. Dubovy, Hong Jiang, Byron L. Lam

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Safety and efficacy of MCO-010 optogenetic therapy in patients with Stargardt disease in USA (STARLIGHT): an open-label multi-center Ph2 trialResearch in context

    Safety and efficacy of MCO-010 optogenetic therapy in patients with Stargardt disease in USA (STARLIGHT): an open-label multi-center Ph2 trialResearch in context by Byron L. Lam, Vitaliy Zak, Victor H. Gonzalez, Ninel Z. Gregori, Sai H. Chavala, Subrata Batabyal, Michael Carlson, Sanghoon Kim, Ananta Ayyagari, Jean Chang, Hayley Lane, Nozhat Choudry, John Koester, Mark Von Tress, Jody Piltz-Seymour, Najam A. Sharif, Stephen H. Tsang, Vinit B. Mahajan, David S. Boyer, Allen C. Ho, Samuel B. Barone, Samarendra K. Mohanty

    Published 2025-09-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Variants in CFAP410 cause a range of retinal and skeletal phenotypes

    Variants in CFAP410 cause a range of retinal and skeletal phenotypes by Ryan E. Schmidt, Amy E. Pohodich, David Birch, Kaylie Jones, Byron L. Lam, Emily H. Jung, Nieraj Jain, Michalis Georgiou, Omar A. Mahroo, Andrew R. Webster, Michel Michaelides, Benjamin Bakall, Alessandro Iannaccone, Ajoy Vincent, Deepika C. Parameswarappa, Elise Heon, Hendrik P. N. Scholl, Lucas Janeschitz-Kriegl, Elias I. Traboulsi, Wadih Zein, Brian P. Brooks, Catherine Cukras, Robert Hufnagel, Tomas S. Aleman, Mohamed M. Sylla, Stephen H. Tsang, Michelle Alabek, Jose Sahel, Michael B. Gorin, Maria M. van Genderen, Katarina Stingl, Milda Reith, Susanne Kohl, Rebeca Azevedo Souza Amaral, Juliana Maria Ferraz Sallum, Andrea L. Vincent, Sarah Hull, Jacque L. Duncan, James V. M. Hanson, Matthias Tedeus, Jordi Maggi, Urs Graf, Samuel Koller, Wolfgang Berger, Christina Gerth-Kahlert, Molly Marra, Lesley A. Everett, Paul Yang, Mark E. Pennesi

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: